Skip to main content
Figure 1 | BMC Complementary and Alternative Medicine

Figure 1

From: Enhancement of gefitinib-induced growth inhibition by Marsdenia tenacissima extract in non-small cell lung cancer cells expressing wild or mutant EGFR

Figure 1

Treatment of non-small cell lung cancer cells with gefitinib or MTE ( M. tenacissima extract) reduced their proliferation potential. (A) H292 and HCC827 cells were treated with the indicated concentrations of gefitinib for 72 h. (B) H292 and HCC827 cells were treated with the indicated concentrations of MTE for 72 h. Cells viability was determined by using the MTT assay as described in the Methods section. The data are expressed in terms of percent of control cells as the means ± SEM. The experiments were repeated at least three times. * P < 0.05, ** P < 0.01 vs. control group.

Back to article page